Skip to content

Author

Naseh A. Algehainy

We have 6 of 63 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

From ecosystem engineering to living computers: integrating dual-paradigm bacterial therapeutics for solid tumor microenvironment reprogramming.

Recent advances in tumor microbiome biology and synthetic biology have made bacteria attractive therapeutic agents capable of reprogramming tumor-associated microbial ecosystems and serving as programmable living systems in solid tumors. In this review, we construct a dual-paradigm framework combining engineered bacter...

A. Elmetwalli, Naseh A. Algehainy, F. Altemani et al. · 0 citations
Review Open access Oct 2026

Immune cell-derived exosomes in the tumor microenvironment: mechanisms of immune evasion and emerging therapeutic strategies in cancer immunotherapy

Tumor-released exosomes have emerged from the shadows of “cellular dust” to be recognized as pivotal mediators of intercellular communication within the tumor microenvironment (TME). These nano-sized vesicles (30–150 nm) carry a complex cargo of proteins, lipids, and nucleic acids that profoundly reshape anti-tumor imm...

Rashid Mir, M. F. Ullah, M. Moawadh et al. · 0 citations
Open access 2026

Eco-Metabolomic Assessment of Aconitum heterophyllum in the Kashmir Himalaya; Integrating Morphological, Edaphic, Phytochemical, Antioxidant and Climatic Factors

: The present study elucidated the integrated relationships among plant morphology, phytochemical composition, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging activity, soil properties, and climatic drivers of Aconitum heterophyllum Wall. ex Royle, a critically endangered medicinal plant endemic to the Kashmir...

M. Nisa, Ishtiyak Ahmad Peerzada, Rashid Mir et al. · 0 citations
Review Open access Jul 2026

Host systemic metabolism and cancer metabolic vulnerabilities: mechanisms and therapeutic opportunities

The thesis that metabolic plasticity—the capacity of cancer cells to dynamically switch between and co-opt multiple metabolic programs—is the primary driver of tumour progression, immune evasion, and resistance to therapy is upheld.

Rashid Mir, J. Barnawi, Naseh A. Algehainy et al. · 0 citations
Jul 2026

Mechanistic Insights into Honey-Mediated Antibacterial Activity Against Enterobacteriaceae: A Multifaceted Approach Targeting Membrane Integrity, Protein Synthesis, and Quorum Sensing Inhibition.

Findings establish honey as a multitarget antimicrobial agent operating through synergistic perturbation of membrane integrity, metabolic inhibition, and virulence attenuation, offering promising therapeutic potential against resistant Enterobacteriaceae.

M. Hassan, Naseh A. Algehainy, Batul Hatem Ghoniem et al. · 0 citations
Open access Sep 2026

Identification of novel and known variants in GAA, MYH6, NEXN, ATA3A, RHBDF1, and ACTA1 genes in coronary artery disease patients by Whole-exome sequencing

High-resolution exome sequencing allows the detection of pathogenic and likely pathogenic variants in critical genes associated with cardiovascular health and provides evidence of functional significance, thereby elucidating complex interactions between genetic factors and enhancing understanding of disease mechanisms.

Rashid Mir, M. F. Ullah, J. Javid et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.